Search Results

NxStage Dialysate Concentrate is a clear, sterile, non-pyrogenic concentrate, provided in 150 ml unit-dose vials, which, when diluted with sterile water in the required proportions, creates a dialysate for use in renal replacement therapy. When diluted, NxStage Dialysate Concentrate yields a dialysate with the following composition:

Sodium 140.0 mEq/L;
Calcium 3.0 mEq/L;
Potassium 2.0 mEq/L ;
Magnesium 1,0 mEq/L;
Chloride 111.0 mEq/L;
L-Lactate 35.0 mEq/L.

AI/ML Overview

This document describes the 510(k) Premarket Notification for the NxStage Dialysate Concentrate. It's important to note that this is a submission for a dialysate concentrate, which is a medical device (a substance used for dialysis), not a diagnostic algorithm or AI software, therefore many of the standard questions regarding AI/ML studies are not applicable.

Here's an analysis of the provided information in the context of the requested categories, highlighting where information is not applicable due to the nature of the device:

1. A table of acceptance criteria and the reported device performance

The acceptance criteria for this device are primarily based on achieving substantial equivalence to existing predicate devices in terms of intended use and technological characteristics, particularly its chemical composition and method of preparation. The performance discussed is about meeting these equivalence criteria rather than quantified performance metrics typically seen in AI/ML studies (like accuracy, sensitivity, specificity).

Acceptance Criteria (from 510(k) Substantial Equivalence Decision Making Process)	Reported Device Performance (as claimed by NxStage Medical, Inc.)
Is the product a device? (Per 21 CFR §201 [321] (h))	YES - NxStage Dialysate Concentrate is a device.
Does the new device have the same intended use as the predicate devices?	YES - The intended use for the NxStage Dialysate Concentrate ("after dilution, is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate") is considered equivalent to those for the predicate devices (NormoCarb Sterile Bicarbonate Concentrate and Baxter Premixed Dialysate for Hemodiafiltration), despite slight variations in wording.
Does the device have technological characteristics that raise new types of safety or effectiveness questions?	NO - "The composition of the NxStage Dialysate Concentrate is equivalent to that of other commercially available hemodialysis concentrates and raises no new types of safety or effectiveness questions. In addition, the packaging, sterility status and method of preparation are equivalent to those of the NormoCarb Sterile Bicarbonate Concentrate." Specifically, the composition is: Sodium 140.0 mEq/L, Calcium 3.0 mEq/L, Potassium 2.0 mEq/L, Magnesium 1.0 mEq/L, Chloride 111.0 mEq/L, L-Lactate 35.0 mEq/L.
Does descriptive or performance information demonstrate equivalence?	YES - NxStage Medical, Inc. "believes that the information provided in this submission clearly describes the NxStage Dialysate Concentrate and demonstrates that it is substantially equivalent to other commercially available hemodialysis concentrates." (Specific performance data beyond composition is not detailed in this summary for comparison, but is implied to be part of the full submission).

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

This information is not applicable as this describes a chemical concentrate, not a data-driven AI/ML device. No test set of data (e.g., medical images, patient records) was used in the manner of an AI/ML study. The "testing" involved chemical analysis and manufacturing process validation to demonstrate composition and sterility, which are not typically described with sample sizes or data provenance in this context.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This is not applicable. There was no "ground truth" to establish through expert consensus as this is a chemical product. The ground truth for a chemical concentrate would be its verified chemical composition, purity, and sterility according to established analytical methods and quality control standards.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This is not applicable. No adjudication method was used for a "test set" in the context of expert review, as this is a chemical product rather than a diagnostic interpretation.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This is not applicable. This is not an AI-assisted device, so no MRMC study involving human readers and AI was conducted.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

This is not applicable. This is not an algorithm; it's a dialysate concentrate.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

The "ground truth" for this device, if one were to loosely apply the term, would be the established chemical composition standards, sterility requirements, and manufacturing specifications for dialysate concentrates. Equivalence was demonstrated by showing the NxStage product meets these standards and is comparable to existing legally marketed devices.

8. The sample size for the training set

This is not applicable. There is no software algorithm or AI model that requires a training set for this device.

9. How the ground truth for the training set was established

This is not applicable. As there is no training set, there is no ground truth for a training set to be established.

In summary, the provided document describes a 510(k) Premarket Notification for a Dialysate Concentrate, a chemical medical device. The "acceptance criteria" revolve around demonstrating substantial equivalence to predicate devices, primarily through matching chemical composition, intended use, and manufacturing processes, rather than performance metrics typically associated with AI/ML systems. Therefore, most of the questions relating to AI/ML study designs are not relevant to this specific submission.

Ask a Question

Ask a specific question about this device

Page 1 of 1